Pharmacogenetics of folate-related drug targets in cancer treatment.
about
Characterizing the network of drugs and their affected metabolic subpathwaysDifferential chemosensitivity to antifolate drugs between RAS and BRAF melanoma cellsPrediction of irinotecan and 5-fluorouracil toxicity and response in patients with advanced colorectal cancer.Polymorphisms in folate-metabolizing enzymes and response to 5-fluorouracil among patients with stage II or III rectal cancer (INT-0144; SWOG 9304).Genetic and environmental determinants of plasma total homocysteine levels: impact of population-wide folate fortification.High dose methotrexate chemotherapy: pharmacokinetics, folate and toxicity in osteosarcoma patients.A comparison of approaches for association studies of polymorphisms and colorectal cancer risk.Folate Intake, MTHFR Polymorphisms, and the Risk of Colorectal Cancer: A Systematic Review and Meta-AnalysisClinical implications of genetic polymorphisms on stomach cancer drug therapy.Predictors of survival and toxicity in patients on adjuvant therapy with 5-fluorouracil for colorectal cancerExpression and alternative splicing of folate pathway genes in HapMap lymphoblastoid cell linesControversial roles of methylenetetrahydrofolate reductase polymorphisms and folate in breast cancer disease.Pharmacogenomics of fluorouracil -based chemotherapy toxicity.Alterations in the expression pattern of MTHFR, DHFR, TYMS, and SLC19A1 genes after treatment of laryngeal cancer cells with high and low doses of methotrexate.Methylenetetrahydrofolate reductase and thymidylate synthase genotypes modify oral mucositis severity following hematopoietic stem cell transplantation.Impact of acute lymphoblastic leukemia therapy on attention and working memory in children.Association of folate transporter SLC19A1 polymorphisms with the outcome of multiple myeloma after chemotherapy and tandem autologous transplantation.
P2860
Q28484558-88F69567-2F4B-4BC2-860E-9D878C343DB3Q33838195-6C8BB38B-C64E-4004-8D2E-946229AE6662Q34565071-F247AC88-7AAE-4766-A415-72FFF9EDB832Q34653433-E60F462D-F25A-45F9-939D-8819D73ED197Q35048208-29E845E9-07CA-4922-B5F9-053A8A8F63A0Q35640471-EDAEDD9B-8FDA-453C-986A-259073CFABF7Q36319083-AAD40FFC-1251-4FC7-8D41-76F77C088C8AQ36355597-85E57DC3-6118-4F98-8865-903CEA741FF4Q36519876-85C1325F-7679-479B-8267-48B6342A4FBCQ37228492-9B161C89-FB79-41BB-92C7-DBEDC4B95318Q37259813-423EF6FA-26F3-4684-9538-6C3DD9F00B63Q38260470-0192E912-A64A-4E03-A367-5019C8931D3EQ38387640-7784D15E-6562-4FE0-9348-98C2B68F0449Q39128356-27085D64-A3DB-4C5B-9CC8-F1DB6D7841C1Q46963338-1FE59DC3-4890-47C1-9FD7-9DF95F18C74CQ51030080-6ECB118D-373A-4AB4-9163-FC80955A982DQ54304968-C2ECB4E5-F8F4-47D0-AEF9-3455B90DA738
P2860
Pharmacogenetics of folate-related drug targets in cancer treatment.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Pharmacogenetics of folate-related drug targets in cancer treatment.
@ast
Pharmacogenetics of folate-related drug targets in cancer treatment.
@en
type
label
Pharmacogenetics of folate-related drug targets in cancer treatment.
@ast
Pharmacogenetics of folate-related drug targets in cancer treatment.
@en
prefLabel
Pharmacogenetics of folate-related drug targets in cancer treatment.
@ast
Pharmacogenetics of folate-related drug targets in cancer treatment.
@en
P2093
P2860
P356
P1433
P1476
Pharmacogenetics of folate-related drug targets in cancer treatment.
@en
P2093
Alanna Boynton
Cornelia M Ulrich
Kim Robien
P2860
P304
P356
10.2217/14622416.6.7.673
P577
2005-10-01T00:00:00Z